Molina Healthcare (NYSE:MOH) Earns “Overweight” Rating from Cantor Fitzgerald

Cantor Fitzgerald restated their overweight rating on shares of Molina Healthcare (NYSE:MOH) in a report released on Tuesday morning, Benzinga reports. They currently have a $406.00 target price on the stock.

MOH has been the subject of several other reports. Wells Fargo & Company increased their price objective on Molina Healthcare from $315.00 to $360.00 and gave the company an equal weight rating in a report on Monday, August 5th. Jefferies Financial Group reduced their price objective on Molina Healthcare from $354.00 to $297.00 and set a hold rating for the company in a report on Wednesday, July 24th. Truist Financial reduced their price objective on Molina Healthcare from $440.00 to $400.00 and set a buy rating for the company in a report on Monday, July 15th. StockNews.com lowered Molina Healthcare from a buy rating to a hold rating in a report on Wednesday, September 18th. Finally, TD Cowen dropped their target price on Molina Healthcare from $412.00 to $351.00 and set a buy rating on the stock in a research report on Wednesday, July 24th. One analyst has rated the stock with a sell rating, seven have issued a hold rating, five have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Hold and a consensus target price of $378.00.

Molina Healthcare Stock Performance

Shares of MOH opened at $331.36 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.57 and a current ratio of 1.57. The stock has a 50 day moving average price of $343.86 and a two-hundred day moving average price of $339.89. The firm has a market capitalization of $19.42 billion, a P/E ratio of 17.98, a P/E/G ratio of 1.21 and a beta of 0.57. Molina Healthcare has a 52 week low of $282.96 and a 52 week high of $423.92.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.73 by $0.13. The company had revenue of $9.88 billion during the quarter, compared to analyst estimates of $9.75 billion. Molina Healthcare had a return on equity of 28.09% and a net margin of 2.84%. Molina Healthcare’s quarterly revenue was up 18.7% on a year-over-year basis. During the same period in the prior year, the company posted $5.65 earnings per share. Equities analysts forecast that Molina Healthcare will post 23.5 earnings per share for the current fiscal year.

Insider Buying and Selling at Molina Healthcare

In other news, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total transaction of $339,210.00. Following the transaction, the director now directly owns 18,025 shares of the company’s stock, valued at $6,114,260.25. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In related news, CAO Maurice Hebert sold 393 shares of the firm’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $346.52, for a total value of $136,182.36. Following the sale, the chief accounting officer now directly owns 9,473 shares of the company’s stock, valued at $3,282,583.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Steven J. Orlando sold 1,000 shares of the firm’s stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $339.21, for a total value of $339,210.00. Following the completion of the sale, the director now directly owns 18,025 shares in the company, valued at $6,114,260.25. The disclosure for this sale can be found here. Company insiders own 1.10% of the company’s stock.

Institutional Trading of Molina Healthcare

Large investors have recently modified their holdings of the business. Cetera Investment Advisers lifted its holdings in Molina Healthcare by 516.4% in the first quarter. Cetera Investment Advisers now owns 10,238 shares of the company’s stock worth $4,206,000 after buying an additional 8,577 shares during the period. BlackBarn Capital Partners LP purchased a new stake in Molina Healthcare in the fourth quarter worth about $15,139,000. BI Asset Management Fondsmaeglerselskab A S lifted its holdings in Molina Healthcare by 69.5% in the first quarter. BI Asset Management Fondsmaeglerselskab A S now owns 11,809 shares of the company’s stock worth $4,851,000 after buying an additional 4,840 shares during the period. Alaska Permanent Fund Corp lifted its holdings in Molina Healthcare by 1,473.4% in the first quarter. Alaska Permanent Fund Corp now owns 5,727 shares of the company’s stock worth $2,353,000 after buying an additional 5,363 shares during the period. Finally, BNP Paribas Financial Markets lifted its holdings in Molina Healthcare by 35.6% in the first quarter. BNP Paribas Financial Markets now owns 56,835 shares of the company’s stock worth $23,350,000 after buying an additional 14,920 shares during the period. 98.50% of the stock is owned by institutional investors.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.